Ionis Pharmaceuticals IONS Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's other comprehensive income unrealized holding gain loss on securities arising during period net of tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's other comprehensive income unrealized holding gain loss on securities arising during period net of tax?
- Ionis Pharmaceuticals (IONS) reported other comprehensive income unrealized holding gain loss on securities arising during period net of tax of -$5.6M in Q1 2026.
- How has Ionis Pharmaceuticals's other comprehensive income unrealized holding gain loss on securities arising during period net of tax changed year-over-year?
- Ionis Pharmaceuticals's other comprehensive income unrealized holding gain loss on securities arising during period net of tax decreased by 443.8% year-over-year, from $1.63M to -$5.6M.
- What does other comprehensive income unrealized holding gain loss on securities arising during period net of tax mean?
- Gains or losses on investments that the company still owns.
- How do you interpret other comprehensive income unrealized holding gain loss on securities arising during period net of tax?
- Reflects market-driven fluctuations in the value of the company's investment portfolio.
- How does other comprehensive income unrealized holding gain loss on securities arising during period net of tax compare across companies?
- Common for companies with large cash reserves or investment portfolios.